ImpediMed Limited (ASX:IPD)

ImpediMed Revenue

In the fiscal year ending June 30, 2025, ImpediMed had annual revenue of 12.72M AUD with 23.31% growth. ImpediMed had revenue of 6.72M in the half year ending June 30, 2025, with 18.05% growth.

• Revenue: 12.72M
• Revenue Growth: +23.31%
• P/S Ratio: 7.52
• Revenue / Employee: 165.25K
• Employees: 77
• Market Cap: 95.70M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	12.72M	2.41M	23.31%
Jun 30, 2024	10.32M	-1.03M	-9.04%
Jun 30, 2023	11.34M	778.00K	7.36%
Jun 30, 2022	10.57M	2.16M	25.65%
Jun 30, 2021	8.41M	2.67M	46.47%